ArticleFrontiers in immunology2022
Identification of Sorafenib as a Treatment for Type 1 Diabetes.
Qin Zeng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ArticleFrontiers in immunology2022
Qin Zeng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.